These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30459031)

  • 21. Toxin-induced hyperthermic syndromes.
    Rusyniak DE; Sprague JE
    Med Clin North Am; 2005 Nov; 89(6):1277-96. PubMed ID: 16227063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin syndrome versus neuroleptic malignant syndrome: a case report.
    Fernández M; Lago L; Alonso MG; Guede A; Benavente JL; Olivares JM
    Actas Esp Psiquiatr; 2018 Mar; 46(2):68-74. PubMed ID: 29616715
    [No Abstract]   [Full Text] [Related]  

  • 23. Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary.
    Dosi R; Ambaliya A; Joshi H; Patell R
    BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24957740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep brain stimulation as a possible treatment of hyperthermia in patients with serotonin syndrome.
    Koleva K; Pavlov O; Nikolov R; Behr R
    Med Hypotheses; 2020 Jun; 139():109704. PubMed ID: 32251940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic malignant syndrome.
    Gohel DR; Zachariah D; Jacob JK
    J Assoc Physicians India; 1999 Sep; 47(9):940. PubMed ID: 10778679
    [No Abstract]   [Full Text] [Related]  

  • 26. [Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].
    Spiess-Kiefer C; Hippius H
    Fortschr Neurol Psychiatr; 1986 May; 54(5):158-70. PubMed ID: 2426164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosing neuroleptic malignant syndrome.
    Gruber MP
    Chest; 2004 May; 125(5):1960-1; author reply 1961. PubMed ID: 15136417
    [No Abstract]   [Full Text] [Related]  

  • 28. Coexistence of serotonin syndrome and neuroleptic malignant syndrome: does it exist?
    Prakash S; Lodha D; Rawat KS
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34400419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differential diagnosis of malignant hyperthermia, febrile catatonia and neuroleptic malignant syndrome. A case comparison].
    Schröder J; Linge C; Wähner A
    Fortschr Neurol Psychiatr; 1988 Mar; 56(3):97-101. PubMed ID: 2896144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin syndrome: a new pediatric intoxication.
    Spirko BA; Wiley JF
    Pediatr Emerg Care; 1999 Dec; 15(6):440-3. PubMed ID: 10608338
    [No Abstract]   [Full Text] [Related]  

  • 31. Recent onset of confusion, limited mobility, and disturbed sleep-wake cycle.
    Rehman HU; Prasad B
    J Fam Pract; 2011 May; 60(5):261-4. PubMed ID: 21544272
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy.
    Hashim H; Zeb-un-Nisa ; Alrukn SA; Al Madani AA
    J Pak Med Assoc; 2014 Apr; 64(4):471-3. PubMed ID: 24864649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Central anticholinergic, neuroleptic malignant and serotonin syndromes : Important differential diagnoses in postoperative impairment of consciousness].
    Hölle T; Purrucker JC; Morath B; Weigand MA; Schmitt FCF
    Anaesthesiologie; 2023 Mar; 72(3):157-165. PubMed ID: 36799968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Mixed Presentation of Serotonin Syndrome Versus Neuroleptic Malignant Syndrome in a 12-Year-Old Boy.
    Ott M; Werneke U
    Pediatr Emerg Care; 2019 May; 35(5):e98. PubMed ID: 30964850
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neuroleptic malignant syndrome].
    Reingardiene D
    Medicina (Kaunas); 2002; 38(1):1-5. PubMed ID: 12474710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuroleptic malignant syndrome--rare diagnosis with high mortality].
    Petersén A; Lundberg L
    Lakartidningen; 2009 Apr 28-May 12; 106(18-19):1273-6. PubMed ID: 19537499
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperthermia caused by drug interactions and adverse reactions.
    Paden MS; Franjic L; Halcomb SE
    Emerg Med Clin North Am; 2013 Nov; 31(4):1035-44. PubMed ID: 24176477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High risk and low prevalence diseases: Serotonin syndrome.
    Spadaro A; Scott KR; Koyfman A; Long B
    Am J Emerg Med; 2022 Nov; 61():90-97. PubMed ID: 36057215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The authors reply.
    Bienvenu OJ; Neufeld KJ; Needham DM
    Crit Care Med; 2013 Feb; 41(2):e20. PubMed ID: 23353975
    [No Abstract]   [Full Text] [Related]  

  • 40. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.